사회: 박정길 (대구경북지회 총무이사)
| 10:00-10:10 | 환영사 | 박수영 (대구경북지회 회장) |
| 인사말 | 정숙향 (대한간학회 회장) | |
| 격려사 | 권영오 (대구경북지회 고문) | |
| 10:10-11:50 | Session 1. Big Data Approaches in Hepatology |
이창형 (대구가톨릭의대), 임영석 (울산의대) |
| 10:10–10:35 | Issues, Sources, and Challenges of Liver Researches with Big Data | 장세영 (경북의대) |
| 10:35–11:00 | Liver Research Articles Using Big Data and Their Impacts on Practice | 김범경 (연세의대) |
| 11:00–11:25 | Methods and Techniques for Big Data Analysis | 정석송 (고려의대) |
| 11:25–11:50 | My Experiences on Big Data Research: Guiding the Best Way | 전대원 (한양의대) |
| 11:50-12:50 | Lunch | |
| 12:50–14:30 | Session 2. Artificial Intelligence (AI) Approaches in Hepatology |
탁원영 (경북의대), 김윤준 (서울의대) |
| 12:50–13:15 | AI Imaging Tools for Diagnosis and Prognostic Prediction of Liver Diseases | 최상현 (울산의대) |
| 13:15–13:40 | AI-Based Prediction Models for Liver-Related Events | 박수영 (경북의대) |
| 13:40–14:05 | AI-Driven Biomarker Discovery for Predicting HCC Treatment Response | 허문행 (서울의대) |
| 14:05–14:30 | My Experiences on AI Research: Guiding the Best Way | 한태수 (한국생명공학연구원) |
| 14:30-14:50 | Coffee Break | |
| 14:50–16:25 | Session 3. Notable Presentations in The Liver Week 2025 |
김형준 (중앙의대), 정우진 (계명의대), 김지훈 (고려의대) |
| 14:50–15:05 | Clinical and Epidemiological Features of Acute Viral Hepatitis in South Korea: A Nationwide Prospective Multicenter Study |
이창훈 (전북의대) |
| 15:05–15:20 | The Effectiveness of Abdominal Doppler Ultrasound, Measurement of Abdominal Fat, and the Value of Swm/Att in the Assessment of Liver Disease |
정승원 (순천향의대) |
| 15:20–15:35 | HCC Risk in Treatment-Naïve Chronic Hepatitis B Patients Treated with Tenofovir Alafenamide or Tenofovir Disoproxil Fumarate: A Korean Nationwide Study |
양지원 (울산의대) |
| 15:35–15:50 | Impact of Hepatic Encephalopathy on Prognosis in Cirrhotic Patients with Acute Decompensation: The Crucial Role of Underlying Liver Function and Coagulation Failure |
김정희 (한림의대) |
| 15:50–16:05 | Real-World Incidence and Predictive Factors of Variceal Bleeding in HCC Patients Treated with Atezolizumab-Bevacizumab |
송정은 (대구가톨릭의대) |
| 16:05–16:15 | 15-Year Trends in HCC: Epidemiology, Treatment, and Outcomes from a Hospital-Based Registry | 김송경 (울산의대) |
| 16:15–16:25 | Cytokine-Induced Killer Cell Immunotherapy Reduces Recurrence in Patients with Early-Stage HCC | 김동현 (연세의대) |
| 16:25-16:30 | 총평 | 황재석 (대구경북지회 고문) |
| 16:30-16:40 | 맺음말 및 경품추첨 | 김윤준 (대한간학회 이사장) |
| 17:00-20:00 | 저녁 식사 | |